Multiple Endocrine Neoplasia
Also known as: Multiple endocrine neoplasias / Multiple endocrine neoplasia [MEN] syndromes / Multiple endocrine neoplasia [MEN] syndrome, unspecified / Multiple endocrine adenomatosis NOS / Multiple endocrine adenomatosis / Multiple endocrine adenomas (morphologic abnormality) / Multiple endocrine neoplasia syndromes / Polyglandular activity in multiple endocrine adenomatosis (disorder) / Polyglandular activity in multiple endocrine adenomatosis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00927 | Famotidine | A histamine H2 receptor antagonist used to treat duodenal ulcers, benign gastric ulcers, GERD, and Zollinger-Ellison syndrome. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00927 | Famotidine | Histamine H2 receptor | target |
| DB00927 | Famotidine | Solute carrier family 22 member 2 | transporter |
| DB00927 | Famotidine | Solute carrier family 22 member 8 | transporter |
| DB00927 | Famotidine | Multidrug and toxin extrusion protein 1 | transporter |
| DB00927 | Famotidine | Cytochrome P450 1A2 | enzyme |
| DB00927 | Famotidine | Solute carrier family 22 member 6 | transporter |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB13925 | Dotatate gallium Ga-68 | 2 | Completed | 1 |
| DB00530 | Erlotinib | 2 | Terminated | 1 |
| DB00104 | Octreotide | 2 | Completed | 1 |
| DB06366 | Pertuzumab | 2 | Terminated | 1 |
| DB00448 | Lansoprazole | 4 | Completed | 1 |